Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT05924971
PHASE2

Aspirin for Postpartum Patients With Preeclampsia

Sponsor: MemorialCare Health System

View on ClinicalTrials.gov

Summary

The purpose of this research study is to evaluate the effect of low-dose aspirin on recovery from severe preeclampsia (a high blood pressure disorder of pregnancy) among women who have given birth. We hypothesize that taking aspirin for the first week after giving birth will enhance recovery from preeclampsia by decreasing the levels of a protein called soluble fms-like tyrosine kinase (sFlt-1), which is thought to be a main contributor to the development of preeclampsia, and speeding up return to a normal blood pressure.

Official title: Acetylsalicylic Acid for Postpartum Preeclampsia: A Pilot Randomized Trial

Key Details

Gender

FEMALE

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

86

Start Date

2023-07-26

Completion Date

2026-12

Last Updated

2025-06-06

Healthy Volunteers

No

Interventions

DRUG

Aspirin 81Mg Ec Tab

Aspirin 81 mg 1 tablet by mouth. Participants randomized to receive aspirin in addition to standard blood pressure management will receive the study medication nightly at 20:00, with first dose initiated within 24 hours of delivery.

Locations (1)

Miller Children's and Women's Hospital, Long Beach/MemorialCare Long Beach

Long Beach, California, United States